An Overview on Leishmania Diagnosis
Leishmaniasis is now accounted as a health problem and categorized as a class I disease (emerging and uncontrolled) by World Health Organization (WHO), causing highly significant morbidity and mortality with different clinical presentations. The incidence of human leishmaniasis is increasing and its...
Main Authors: | Hossein Rezvan, Ali reza Nourian, Sahar Hamoon Navard |
---|---|
Format: | Article |
Language: | English |
Published: |
Pasteur Institute of Iran
2017-01-01
|
Series: | Journal of Medical Microbiology and Infectious Diseases |
Subjects: | |
Online Access: | http://jommid.pasteur.ac.ir/article-1-118-en.html |
Similar Items
-
Expression of Cytokine Genes in Leishmania major-Infected BALB/c Mice Treated with Mesenchymal Stem Cells
by: Sahar Hamoon Navard, et al.
Published: (2020-01-01) -
Inhibitory Effects of Leishmania Mexicana infection on MHC-I Expression in Bone Marrow Derived Dendritic Cells
by: Hossein Rezvan, et al.
Published: (2022-12-01) -
Therapeutic effects of mesenchymal stem cells on cutaneous leishmaniasis lesions caused by Leishmania major
by: Sahar Hamoon Navard, et al.
Published: (2020-12-01) -
Predominance of Leishmania major and rare occurrence of Leishmania tropica with haplotype variability at the center of Iran
by: Amir Hossein Zahirnia, et al. -
Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel
by: Michal Solomon, et al.
Published: (2019-04-01)